Karin Jordan

15.0k total citations · 10 hit papers
112 papers, 7.4k citations indexed

About

Karin Jordan is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Karin Jordan has authored 112 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 38 papers in Oncology and 23 papers in Physiology. Recurrent topics in Karin Jordan's work include Nausea and vomiting management (45 papers), Anesthesia and Pain Management (30 papers) and Pathogenesis and Treatment of Hiccups (20 papers). Karin Jordan is often cited by papers focused on Nausea and vomiting management (45 papers), Anesthesia and Pain Management (30 papers) and Pathogenesis and Treatment of Hiccups (20 papers). Karin Jordan collaborates with scholars based in Germany, United States and United Kingdom. Karin Jordan's co-authors include Solange Peters, John B.A.G. Haanen, Franck Carbonnel, Caroline Robert, James Larkin, Keith M. Kerr, Matti Aapro, Alex Molassiotis, Rebecca Clark-Snow and Paul J. Hesketh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Karin Jordan

103 papers receiving 7.2k citations

Hit Papers

Management of toxicities from immunotherapy: ESMO Clinica... 2016 2026 2019 2022 2017 2022 2017 2016 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2017 1.7k citations John B.A.G. Haanen, Franck Carbonnel et al. Annals of Oncology profile →
  2. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 565 citations John B.A.G. Haanen, Franck Carbonnel et al. Annals of Oncology profile →
  3. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 397 citations Paul J. Hesketh, Rebecca Clark-Snow et al. profile →
  4. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
    2016 397 citations Fausto Roila, Alex Molassiotis et al. Annals of Oncology profile →
  5. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
    2020 340 citations Karin Jordan et al. Annals of Oncology profile →
  6. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
    2020 323 citations Alessandra Fabi, Ravi Bhargava et al. Annals of Oncology profile →
  7. Bone health in cancer: ESMO Clinical Practice Guidelines
    2020 294 citations Robert E. Coleman, Peyman Hadji et al. Annals of Oncology profile →
  8. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†
    2020 281 citations Karin Jordan et al. Annals of Oncology profile →
  9. Antiemetics: ASCO Guideline Update
    2020 224 citations Paul J. Hesketh, Rebecca Clark-Snow et al. profile →
  10. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
    2023 172 citations Anna Falanga, Cihan Ay et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Jordan Germany 33 4.1k 2.0k 1.4k 961 729 112 7.4k
Bernardo L. Rapoport South Africa 36 3.3k 0.8× 2.0k 1.0× 743 0.5× 1.1k 1.1× 469 0.6× 199 6.6k
Paolo Bossi Italy 51 3.9k 0.9× 2.8k 1.3× 3.2k 2.3× 733 0.8× 1.3k 1.8× 346 8.8k
Matthew J. Grainge United Kingdom 51 2.5k 0.6× 1.9k 0.9× 1.0k 0.8× 605 0.6× 1.8k 2.4× 152 11.2k
Jonas Manjer Sweden 52 3.7k 0.9× 1.8k 0.9× 1.5k 1.1× 705 0.7× 2.2k 3.0× 220 8.9k
Jørn Herrstedt Denmark 42 3.4k 0.8× 3.6k 1.8× 952 0.7× 2.4k 2.5× 517 0.7× 172 8.4k
Irene Helenowski United States 39 1.7k 0.4× 877 0.4× 967 0.7× 415 0.4× 898 1.2× 232 5.7k
Vittorio Gebbia Italy 40 4.2k 1.0× 1.3k 0.6× 2.2k 1.6× 310 0.3× 1.0k 1.4× 290 7.0k
Hans Wildiers Belgium 54 7.5k 1.8× 1.2k 0.6× 3.3k 2.4× 1.7k 1.8× 2.7k 3.8× 390 14.6k
James L. Wade United States 45 4.3k 1.1× 796 0.4× 2.0k 1.5× 241 0.3× 1.3k 1.8× 153 7.6k
Laurel A. Habel United States 47 3.7k 0.9× 2.0k 1.0× 1.8k 1.3× 477 0.5× 3.2k 4.4× 200 9.9k

Countries citing papers authored by Karin Jordan

Since Specialization
Citations

This map shows the geographic impact of Karin Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Jordan more than expected).

Fields of papers citing papers by Karin Jordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Jordan. The network helps show where Karin Jordan may publish in the future.

Co-authorship network of co-authors of Karin Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Jordan. A scholar is included among the top collaborators of Karin Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Jordan. Karin Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeo, Winnie, Giampaolo Bianchini, Javier Cortés, et al.. (2025). Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. Future Oncology. 21(10). 1261–1272.
2.
Jordan, Karin, Evandro de Azambuja, Franziska Jahn, et al.. (2025). Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. European Journal of Cancer. 222. 115451–115451. 1 indexed citations
3.
Jordan, Berit, Franziska Jahn, & Karin Jordan. (2025). Peripheral neuropathy: from guidelines to clinical practise. Current Opinion in Oncology. 37(2). 168–174.
4.
Jordan, Karin, Alexandre Chan, Richard J. Gralla, et al.. (2023). Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation. Supportive Care in Cancer. 32(1). 53–53. 12 indexed citations
5.
Schwartzberg, Lee S., Hirotoshi Iihara, Matti Aapro, et al.. (2023). 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive Care in Cancer. 32(1). 45–45. 9 indexed citations
6.
Ruhlmann, Christina H., Karin Jordan, Franziska Jahn, et al.. (2023). 2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting. Supportive Care in Cancer. 32(1). 26–26. 3 indexed citations
7.
Falanga, Anna, Cihan Ay, Marcello Di Nisio, et al.. (2023). Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Annals of Oncology. 34(5). 452–467. 172 indexed citations breakdown →
8.
Zarkavelis, George, Ciska Verbaanderd, Nathan I. Cherny, et al.. (2022). Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines. ESMO Open. 8(1). 100604–100604. 9 indexed citations
9.
Jordan, Berit, Karolina Benesova, J.C. Hassel, Wolfgang Wick, & Karin Jordan. (2021). How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors. ESMO Open. 6(6). 100317–100317. 21 indexed citations
10.
Fabi, Alessandra, Ravi Bhargava, Sonia Fatigoni, et al.. (2020). Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Annals of Oncology. 31(6). 713–723. 323 indexed citations breakdown →
11.
Benesova, Karolina, L. Diekmann, H.-M. Lorenz, et al.. (2020). 1809O TRheuMa registry provides real world data on rheumatic immune-related adverse events. Annals of Oncology. 31. S1046–S1046.
12.
Coleman, Robert E., Peyman Hadji, Jean‐Jacques Body, et al.. (2020). Bone health in cancer: ESMO Clinical Practice Guidelines. Annals of Oncology. 31(12). 1650–1663. 294 indexed citations breakdown →
13.
Jordan, Berit, Franziska Jahn, Sandra Sauer, & Karin Jordan. (2019). Prevention and Management of Chemotherapy-Induced Polyneuropathy. Breast Care. 14(2). 79–84. 32 indexed citations
14.
Bossi, Paolo, Andrea Antonuzzo, Nathan I. Cherny, et al.. (2018). Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology. 29(Suppl 4). iv126–iv142. 84 indexed citations
15.
16.
Haanen, John B.A.G., Franck Carbonnel, Caroline Robert, et al.. (2017). Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 28(Suppl 4). iv119–iv142. 1739 indexed citations breakdown →
17.
Jordan, Karin, Fausto Roila, Alex Molassiotis, et al.. (2010). Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009. Supportive Care in Cancer. 19(S1). 37–42. 35 indexed citations
18.
Schmoll, Hans‐Joachim & Karin Jordan. (2009). Current treatment of high risk testis cancer. European Journal of Cancer. 45. 433–435. 2 indexed citations
19.
Jordan, Karin, et al.. (1998). Some Biological Actions of Alkylglycerols from Shark Liver Oil. The Journal of Alternative and Complementary Medicine. 4(1). 87–99. 51 indexed citations
20.
Greenlee, John, et al.. (1992). Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.. PubMed Central. 156(2). 199–202. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernardo L. Rapoport Breakdown of academic impact, for papers by Paolo Bossi Breakdown of academic impact, for papers by Matthew J. Grainge Breakdown of academic impact, for papers by Jonas Manjer Breakdown of academic impact, for papers by Jørn Herrstedt Breakdown of academic impact, for papers by Irene Helenowski Breakdown of academic impact, for papers by Vittorio Gebbia Breakdown of academic impact, for papers by Hans Wildiers Breakdown of academic impact, for papers by James L. Wade Breakdown of academic impact, for papers by Laurel A. Habel
Rankless by CCL
2026